Arca Biopharma Company Profile (NASDAQ:ABIO)

About Arca Biopharma (NASDAQ:ABIO)

Arca Biopharma logoARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical trial for the treatment of atrial fibrillation (AF) in patients with heart failure with reduced left ventricular ejection fraction (HFREF). Gencaro is considered part of the beta-blocker class of compounds because of its property of blocking both beta-1 and beta-2, receptors in the heart. The blocking of these receptors prevents the receptor from binding with other molecules, primarily the neurotransmitter norepinephrine (NE), which activate these receptors. The Company is conducting a Phase IIB/III clinical trial of Gencaro, known as GENETIC-AF.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ABIO
  • CUSIP: N/A
  • Web: www.arcabiopharma.com
Capitalization:
  • Market Cap: $21.46 million
  • Outstanding Shares: 9,130,000
Average Prices:
  • 50 Day Moving Avg: $2.45
  • 200 Day Moving Avg: $2.51
  • 52 Week Range: $2.15 - $3.93
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.97
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: $2.44 per share
  • Price / Book: 0.96
Profitability:
  • EBIDTA: ($16,290,000.00)
  • Return on Equity: -47.28%
  • Return on Assets: -44.61%
Debt:
  • Current Ratio: 11.06%
  • Quick Ratio: 11.06%
Misc:
  • Average Volume: 25,543 shs.
  • Beta: 2.16
  • Short Ratio: 3.5
 

Frequently Asked Questions for Arca Biopharma (NASDAQ:ABIO)

What is Arca Biopharma's stock symbol?

Arca Biopharma trades on the NASDAQ under the ticker symbol "ABIO."

How were Arca Biopharma's earnings last quarter?

Arca Biopharma Inc (NASDAQ:ABIO) announced its quarterly earnings results on Monday, May, 15th. The company reported ($0.48) EPS for the quarter. View Arca Biopharma's Earnings History.

Who are some of Arca Biopharma's key competitors?

How do I buy Arca Biopharma stock?

Shares of Arca Biopharma can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Arca Biopharma stock cost?

One share of Arca Biopharma stock can currently be purchased for approximately $2.35.

Analyst Ratings

Consensus Ratings for Arca Biopharma (NASDAQ:ABIO) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Arca Biopharma (NASDAQ:ABIO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/23/2016Royal Bank of CanadaReiterated RatingSector Perform$5.00 -> $4.00N/AView Rating Details
2/23/2016Cowen and CompanyReiterated RatingMarket Perform$5.50 -> $4.00N/AView Rating Details
(Data available from 5/27/2015 forward)

Earnings

Earnings History for Arca Biopharma (NASDAQ:ABIO)
Earnings by Quarter for Arca Biopharma (NASDAQ:ABIO)
Earnings History by Quarter for Arca Biopharma (NASDAQ:ABIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/15/2017Q1 2017($0.48)ViewN/AView Earnings Details
11/14/2016Q3 2016($0.51)ViewN/AView Earnings Details
8/9/2016Q216($0.43)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Arca Biopharma (NASDAQ:ABIO)
Current Year EPS Consensus Estimate: $-1.75 EPS
Next Year EPS Consensus Estimate: $-1.19 EPS

Dividends

Dividend History for Arca Biopharma (NASDAQ:ABIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Arca Biopharma (NASDAQ:ABIO)
Insider Ownership Percentage: 2.46%
Institutional Ownership Percentage: 50.54%
Insider Trades by Quarter for Arca Biopharma (NASDAQ:ABIO)
Insider Trades by Quarter for Arca Biopharma (NASDAQ:ABIO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/2/2017Daniel J MitchellDirectorBuy11,000$2.71$29,810.00View SEC Filing  
4/4/2017Christopher David OzeroffVPSell418$2.41$1,007.38View SEC Filing  
4/4/2017Michael R. BristowInsiderSell720$2.41$1,735.20View SEC Filing  
4/4/2017Thomas A. KeuerCOOSell390$2.41$939.90View SEC Filing  
4/3/2017Brian L. SelbyVPSell1,114$2.46$2,740.44View SEC Filing  
3/24/2017Robert E ConwayDirectorBuy25,000$2.59$64,750.00View SEC Filing  
2/28/2017Michael R. BristowInsiderSell763$2.61$1,991.43View SEC Filing  
2/28/2017Thomas A. KeuerCOOSell465$2.61$1,213.65View SEC Filing  
10/18/2016Thomas A. KeuerCOOSell483$2.45$1,183.35View SEC Filing  
9/20/2016Christopher David OzeroffVPSell1,185$2.89$3,424.65View SEC Filing  
9/20/2016Michael R. BristowInsiderSell1,972$2.89$5,699.08View SEC Filing  
9/20/2016Thomas A. KeuerCOOSell714$2.89$2,063.46View SEC Filing  
9/19/2016Brian L. SelbyVPSell476$2.91$1,385.16View SEC Filing  
4/5/2016Christopher David OzeroffVPSell366$3.52$1,288.32View SEC Filing  
4/5/2016Michael R BristowInsiderSell724$3.52$2,548.48View SEC Filing  
4/5/2016Thomas A KeuerCOOSell384$3.52$1,351.68View SEC Filing  
4/4/2016Brian L SelbyVPSell1,114$3.52$3,921.28View SEC Filing  
3/1/2016Christopher David OzeroffVPSell458$3.51$1,607.58View SEC Filing  
3/1/2016Michael R. BristowInsiderSell752$3.50$2,632.00View SEC Filing  
3/1/2016Thomas A. KeuerCOOSell457$3.53$1,613.21View SEC Filing  
9/18/2015Christopher David OzeroffVPSell1,129$6.32$7,135.28View SEC Filing  
3/2/2015Brian L SelbyVPSell1,125$0.71$798.75View SEC Filing  
3/2/2015Michael R BristowInsiderSell5,446$0.71$3,866.66View SEC Filing  
1/16/2015Riley MccormackMajor ShareholderSell350,000$0.76$266,000.00View SEC Filing  
1/7/2015Riley MccormackMajor ShareholderSell550,000$0.92$506,000.00View SEC Filing  
9/18/2014Michael R BristowCEOSell13,853$1.30$18,008.90View SEC Filing  
9/18/2014Patrick M WheelerCFOSell8,246$1.31$10,802.26View SEC Filing  
2/4/2014Riley MccormackMajor ShareholderBuy1,000,000$1.70$1,700,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Arca Biopharma (NASDAQ:ABIO)
Latest Headlines for Arca Biopharma (NASDAQ:ABIO)
Source:
DateHeadline
americanbankingnews.com logoArca Biopharma Inc (ABIO) Releases Quarterly Earnings Results
www.americanbankingnews.com - May 16 at 1:10 PM
reuters.com logoBRIEF-ARCA Biopharma Q1 loss per share $0.48
www.reuters.com - May 15 at 3:15 PM
finance.yahoo.com logoARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business Update
finance.yahoo.com - May 15 at 3:15 PM
americanbankingnews.com logoDaniel J. Mitchell Buys 11,000 Shares of Arca Biopharma Inc (ABIO) Stock
www.americanbankingnews.com - May 4 at 1:26 AM
americanbankingnews.com logoArca Biopharma (ABIO) Receives News Sentiment Rating of 0.56
www.americanbankingnews.com - May 3 at 8:28 AM
americanbankingnews.com logoSomewhat Positive Press Coverage Likely to Affect Arca Biopharma (ABIO) Share Price
www.americanbankingnews.com - April 27 at 2:04 PM
News IconBRIEF-Arca Biopharma Inc files for mixed shelf of up to $75 mln
www.businessinsider.com - April 27 at 1:26 AM
finance.yahoo.com logoARCA biopharma Announces 200th Patient Randomized into the GENETIC-AF Seamless Design Phase 2B/3 Clinical Trial
finance.yahoo.com - April 26 at 3:24 PM
americanbankingnews.com logoFavorable News Coverage Extremely Likely to Affect Arca Biopharma (ABIO) Stock Price
www.americanbankingnews.com - April 22 at 9:15 AM
finance.yahoo.com logoARCA biopharma to Present at the Planet MicroCap Showcase 2017 Investor Conference
finance.yahoo.com - April 18 at 3:15 PM
americanbankingnews.com logoArca Biopharma Inc (ABIO) Director Purchases $64,750.00 in Stock
www.americanbankingnews.com - March 27 at 10:48 PM
rttnews.com logoFDA Nod For Parkinson's Drug, ABIO Awaits Data In Q3, Busy Year Ahead For VKTX
www.rttnews.com - March 22 at 3:17 PM
businesswire.com logoARCA biopharma Announces Fiscal Year 2016 Financial Results and Provides Business Update
www.businesswire.com - March 21 at 8:22 PM
rttnews.com logoNOVN Moves Ahead, PTCT Finally Achieves It, TGTX Gets GENUINE Reaction
www.rttnews.com - March 7 at 3:15 PM
finance.yahoo.com logoARCA biopharma Announces 175th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial
finance.yahoo.com - March 6 at 8:56 AM
biz.yahoo.com logoARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - March 1 at 8:16 PM
thestreet.com logoAnders Hove, M.D. (Photo: Business Wire)
www.thestreet.com - February 21 at 3:32 PM
finance.yahoo.com logoAnders Hove, MD Joins ARCA biopharma Board of Directors
finance.yahoo.com - February 21 at 3:32 PM
biz.yahoo.com logoARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
biz.yahoo.com - February 21 at 3:32 PM
finance.yahoo.com logoARCA biopharma Announces 150th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial
finance.yahoo.com - January 18 at 3:39 PM
biz.yahoo.com logoARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit
biz.yahoo.com - January 11 at 8:17 PM
finance.yahoo.com logoARCA biopharma to Present at Biotech Showcase 2017
finance.yahoo.com - January 4 at 3:17 PM
finance.yahoo.com logoStockNewsNow.com Publishes New SNNLive Video Interview with ARCA biopharma, Inc. Provides Company Overview and Discusses Clinical Development
finance.yahoo.com - November 15 at 12:32 PM
businesswire.com logoARCA biopharma Announces Third Quarter 2016 Financial Results and Provides Business Update
www.businesswire.com - November 14 at 8:55 PM
reuters.com logoBRIEF-Arca Biopharma Q3 loss per share $0.51
www.reuters.com - November 14 at 8:55 PM
thestreet.com logoDr. Michael R. Bristow, President And CEO, ARCA Biopharma, Inc.
www.thestreet.com - October 7 at 8:02 AM
finance.yahoo.com logoARCA biopharma to Present at the Dawson James Securities Second Annual Growth Stock Conference
finance.yahoo.com - October 4 at 3:15 PM
finance.yahoo.com logoARCA biopharma Named Winner of Corporate LiveWire Healthcare and Lifesciences Innovation Award
finance.yahoo.com - September 13 at 3:15 PM
rttnews.com logoEARS Faces The Music, ABIO On Track, TEVA Gets EU Nod For Asthma Drug
www.rttnews.com - August 19 at 11:29 AM
reuters.com logoBRIEF-Arca says 100th patient randomized into the genetic-AF phase 2b/3 clinical trial
www.reuters.com - August 18 at 3:15 PM
streetinsider.com logoForm 4 ARCA biopharma, Inc. For: Jun 09 Filed by: Selby Brian L.
www.streetinsider.com - June 15 at 3:16 PM
biz.yahoo.com logoARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o
biz.yahoo.com - June 13 at 5:01 PM
businesswire.com logoARCA biopharma Announces First Quarter 2016 Financial Results and Provides Business Update - Business Wire (press release)
www.businesswire.com - May 12 at 9:47 AM
biz.yahoo.com logoARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - May 11 at 4:49 PM
biz.yahoo.com logoARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - April 18 at 4:31 PM
businesswire.com logoARCA biopharma Announces 75th Patient Enrolled in GENETIC-AF Phase 2B/3 Clinical Trial - Business Wire (press release)
www.businesswire.com - April 18 at 10:27 AM
finance.yahoo.com logoARCA biopharma Announces 75th Patient Enrolled in GENETIC-AF Phase 2B/3 Clinical Trial
finance.yahoo.com - April 18 at 9:00 AM
finance.yahoo.com logoARCA BIOPHARMA, INC. Financials
finance.yahoo.com - March 23 at 1:04 PM
biz.yahoo.com logoARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
biz.yahoo.com - March 17 at 4:44 PM
finance.yahoo.com logoGENETIC-AF Clinical Trial for Prevention of Atrial Fibrillation Enrolls 50th Patient
finance.yahoo.com - January 12 at 8:30 AM
finance.yahoo.com logoApplying Lessons from KBIO
finance.yahoo.com - December 8 at 9:00 AM
finance.yahoo.com logo2 Micro-Cap Opportunities in Atrial Fibrillation
finance.yahoo.com - November 30 at 9:38 AM
finance.yahoo.com logoBiotechs Under 20 Dollars Poised to Breakout
finance.yahoo.com - November 23 at 3:07 PM

Social

Chart

Arca Biopharma (ABIO) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by MarketBeat.com Staff